These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25429309)

  • 1. Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.
    Marquie M; Locascio JJ; Rentz DM; Becker JA; Hedden T; Johnson KA; Growdon JH; Gomperts SN
    Alzheimers Res Ther; 2014; 6(5-8):52. PubMed ID: 25429309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
    Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
    Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
    Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
    Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
    Yoo HS; Jeong SH; Oh KT; Lee S; Sohn YH; Ye BS; Yun M; Lee PH
    Brain; 2022 Dec; 145(12):4448-4458. PubMed ID: 35234856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies.
    Kang SW; Jeon S; Lee YG; Park M; Baik K; Jung JH; Chung SJ; Yoo HS; Jeong SH; Yun M; Lee PH; Sohn YH; Evans AC; Ye BS
    Sci Rep; 2021 Jul; 11(1):14394. PubMed ID: 34257349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between clinical symptoms and striatal DAT uptake in patients with DLB.
    Shimizu S; Hirose D; Namioka N; Kanetaka H; Hirao K; Hatanaka H; Takenoshita N; Kaneko Y; Ogawa Y; Umahara T; Sakurai H; Hanyu H
    Ann Nucl Med; 2017 Jun; 31(5):390-398. PubMed ID: 28361209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases.
    Rieckmann A; Gomperts SN; Johnson KA; Growdon JH; Van Dijk KR
    Neuroimage Clin; 2015; 8():554-9. PubMed ID: 26137443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
    Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and striatal dopamine transporter predictors of β-amyloid in dementia with Lewy bodies.
    Yoo HS; Lee S; Chung SJ; Lee YH; Ye BS; Sohn YH; Yun M; Lee PH
    Neurology; 2020 Mar; 94(13):e1344-e1352. PubMed ID: 32086384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.
    Massa F; Arnaldi D; De Cesari F; Girtler N; Brugnolo A; Grazzini M; Bauckneht M; Meli R; Morbelli S; Pardini M; Sambuceti G; De Carli F; Tiraboschi P; Nobili F
    Neurobiol Aging; 2019 Apr; 76():9-17. PubMed ID: 30611093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
    Kamagata K; Nakatsuka T; Sakakibara R; Tsuyusaki Y; Takamura T; Sato K; Suzuki M; Hori M; Kumamaru KK; Inaoka T; Aoki S; Terada H
    Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
    Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease.
    Ransmayr G; Seppi K; Donnemiller E; Luginger E; Marksteiner J; Riccabona G; Poewe W; Wenning GK
    Eur J Nucl Med; 2001 Oct; 28(10):1523-8. PubMed ID: 11685496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
    Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
    Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction.
    Chiu PY; Wei CY; Hung GU; Wu SL
    Front Aging Neurosci; 2021; 13():709215. PubMed ID: 34456711
    [No Abstract]   [Full Text] [Related]  

  • 19. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease.
    Pezzoli S; Cagnin A; Antonini A; Venneri A
    Postgrad Med; 2019 Sep; 131(7):509-522. PubMed ID: 31422718
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic correlate of memory-deficit awareness in dementia with Lewy bodies: Implication in cortical midline structure.
    Iizuka T; Kameyama M
    Psychiatry Res Neuroimaging; 2017 Nov; 269():43-47. PubMed ID: 28938220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.